347 related articles for article (PubMed ID: 14652441)
1. Re-evaluation of reading frame-shift hypothesis in Duchenne and Becker muscular dystrophy.
Pandey GS; Kesari A; Mukherjee M; Mittal RD; Mittal B
Neurol India; 2003 Sep; 51(3):367-9. PubMed ID: 14652441
[TBL] [Abstract][Full Text] [Related]
2. Frameshift deletion mechanisms in Egyptian Duchenne and Becker muscular dystrophy families.
Elhawary NA; Shawky RM; Hashem N
Mol Cells; 2004 Oct; 18(2):141-9. PubMed ID: 15528988
[TBL] [Abstract][Full Text] [Related]
3. Deletion analysis of the dystrophin gene in Duchenne and Becker muscular dystrophy patients: use in carrier diagnosis.
Kumari D; Mital A; Gupta M; Goyle S
Neurol India; 2003 Jun; 51(2):223-6. PubMed ID: 14571009
[TBL] [Abstract][Full Text] [Related]
4. [Deletions in the dystrophin gene and its phenotype expression].
Lalić T; Guć-Sćekić M; Djurisić M; Radivojević D; Zamurović D; Todorović S
Srp Arh Celok Lek; 2001; 129 Suppl 1():3-5. PubMed ID: 15637982
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between genotypes and phenotypes in pseudohypertrophic muscular dystrophy].
Feng SW; Liang YY; Cao JQ; Song XM; Zhang C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):653-7. PubMed ID: 23225043
[TBL] [Abstract][Full Text] [Related]
6. Proximal dystrophin gene deletions and protein alterations in becker muscular dystrophy.
Novaković I; Bojić D; Todorović S; Apostolski S; Luković L; Stefanović D; Milasin J
Ann N Y Acad Sci; 2005 Jun; 1048():406-10. PubMed ID: 16154963
[TBL] [Abstract][Full Text] [Related]
7. Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy.
Béroud C; Tuffery-Giraud S; Matsuo M; Hamroun D; Humbertclaude V; Monnier N; Moizard MP; Voelckel MA; Calemard LM; Boisseau P; Blayau M; Philippe C; Cossée M; Pagès M; Rivier F; Danos O; Garcia L; Claustres M
Hum Mutat; 2007 Feb; 28(2):196-202. PubMed ID: 17041910
[TBL] [Abstract][Full Text] [Related]
8. Molecular deletion patterns in Duchenne and Becker muscular dystrophy patients from KwaZulu Natal.
Hallwirth Pillay KD; Bill PL; Madurai S; Mubaiwa L; Rapiti P
J Neurol Sci; 2007 Jan; 252(1):1-3. PubMed ID: 17141273
[TBL] [Abstract][Full Text] [Related]
9. Deletion mutations in the dystrophin gene of Saudi patients with Duchenne and Becker muscular dystrophy.
Al-Jumah M; Majumdar R; Al-Rajeh S; Chaves-Carballo E; Salih MM; Awada A; Al-Shahwan S; Al-Uthaim S
Saudi Med J; 2002 Dec; 23(12):1478-82. PubMed ID: 12518196
[TBL] [Abstract][Full Text] [Related]
10. Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene.
Deburgrave N; Daoud F; Llense S; Barbot JC; Récan D; Peccate C; Burghes AH; Béroud C; Garcia L; Kaplan JC; Chelly J; Leturcq F
Hum Mutat; 2007 Feb; 28(2):183-95. PubMed ID: 17041906
[TBL] [Abstract][Full Text] [Related]
11. [Molecular genetics and problems found in genetic diagnosis of Duchenne Becker muscular dystrophy].
Takeshima Y; Matsuo M
Nihon Rinsho; 1997 Dec; 55(12):3120-5. PubMed ID: 9436421
[TBL] [Abstract][Full Text] [Related]
12. [Molecular pathology of Duchenne and Becker muscular dystrophy].
Gilgenkrantz H; Chelly J; Récan D; Chafey P; Kaplan JC
C R Seances Soc Biol Fil; 1992; 186(4):349-53. PubMed ID: 1301222
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism in muscle biopsies of Duchenne and Becker muscular dystrophy patients.
Anand A; Prabhakar S; Kaul D
Neurol India; 1999 Sep; 47(3):218-23. PubMed ID: 10514583
[TBL] [Abstract][Full Text] [Related]
14. [From gene to disease; the dystrophin gene involved in Duchenne and Becker muscular dystrophy].
den Dunnen JT; de Visser M; Bakker E
Ned Tijdschr Geneeskd; 2002 Feb; 146(8):364-7. PubMed ID: 11887623
[TBL] [Abstract][Full Text] [Related]
15. MLPA analysis/complete sequencing of the DMD gene in a group of Bulgarian Duchenne/Becker muscular dystrophy patients.
Todorova A; Todorov T; Georgieva B; Lukova M; Guergueltcheva V; Kremensky I; Mitev V
Neuromuscul Disord; 2008 Aug; 18(8):667-70. PubMed ID: 18653336
[TBL] [Abstract][Full Text] [Related]
16. Amplification of selected exons by polymerase chain reaction enables determination of the translational reading frame of dystrophin mRNA resulting from deletion mutations.
Kitoh Y; Matsuo M; Nishio H; Nakamura H
Kobe J Med Sci; 1994 Apr; 40(2):39-48. PubMed ID: 7823533
[TBL] [Abstract][Full Text] [Related]
17. Genotype-phenotype correlation in Duchenne/Becker muscular dystrophy patients seen at Lucknow.
Mittal B; Singh V; Mishra S; Sinha S; Mittal RD; Chaturvedi LS; Danda S; Pradhan S; Agarwal SS
Indian J Med Res; 1997 Jan; 105():32-8. PubMed ID: 9029833
[TBL] [Abstract][Full Text] [Related]
18. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule.
Aartsma-Rus A; Van Deutekom JC; Fokkema IF; Van Ommen GJ; Den Dunnen JT
Muscle Nerve; 2006 Aug; 34(2):135-44. PubMed ID: 16770791
[TBL] [Abstract][Full Text] [Related]
19. Duchenne and Becker muscular dystrophy: from gene diagnosis to molecular therapy.
Matsuo M
IUBMB Life; 2002 Mar; 53(3):147-52. PubMed ID: 12102170
[TBL] [Abstract][Full Text] [Related]
20. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]